Novartis· @Novartis · X·· 2025-10-28AI 评分30
AI 导读
2025年第三季度，诺华实现了稳健的销售额和核心营业收入增长，管线进展强劲。 我们的关键增长驱动力表现良好，并取得了重要的创新里程碑，包括一项FDA批准和积极的数据读出，这有望支撑我们到2030年及以后的增长。 https://novartis.social/6018t8JRE #NVSQ32025
正文
In Q3 2025, Novartis delivered solid sales and core operating income growth with strong pipeline progress.
Our key growth drivers performed well, and we had important innovation milestone achievements including an FDA approval and positive data readout that has the potential to underpin our growth through 2030 and beyond. https://novartis.social/6018t8JRE
#NVSQ32025
来源：Novartis · x.com